The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.
In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...
The United States president Donald Trump announced that the U.S will shortly introduce a "major" tariff on pharmaceutical imports. “We are going to be announcing very shortly a major tariff on
The anti-obesity drug market in India experienced a remarkable fourfold increase from March 2021 to March 2025 according to PharmaTrac data with a value growth from ?133 crore to ?576 crore. The market points to lifestyle disorders as well as consume
The well-known migraine drug Vasograin has a new formulation called Vasograin EC, which was announced by Cadila Pharmaceuticals. The updated formulation is currently manufactured in a US FDA-approved facility that complies with global quality and....
Researchers at the University of South Australia (UniSA) are working on a laparoscopic probe that uses quantum technology to enhance the detection of gastrointestinal cancers. Supported by the federal government's Economic Accelerator...
The World Health Organization (WHO) has officially re-designated the Medicines and Healthcare products Regulatory Agency's (MHRA) Science and Research group as a Collaborating Centre for the Standardisation and Evaluation of Biologicals for...
Standard Operating Procedures (SOP) have been framed by the CDSCO for drugs manufactured in Special Economic Zones for transfer...
Donald Trump's remarks threatening massive tariffs on all imports of pharmaceuticals led to a crash in the Indian pharmaceutical stocks. The news unsettled the Indian...
Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.